Technical Analysis for RGS - Regeneus Ltd  

Grade Last Price % Change Price Change
grade C 0.083 -8.79% -0.008
RGS closed down 8.79 percent on Wednesday, December 11, 2019, on approximately normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
See historical RGS trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion -8.79%
Narrow Range Bar Range Contraction -12.63%
Wide Bands Range Expansion -12.63%
Gapped Up Strength -12.63%
Narrow Range Bar Range Contraction -7.78%
Wide Bands Range Expansion -7.78%
Gapped Down Weakness -7.78%
Calm After Storm Range Contraction -12.63%
Older signals for RGS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Interactive chart

Profile

Regeneus Ltd is a clinical-stage regenerative medicine company. The Company is engaged in developing cell-based therapies for human and animal health markets, with a focus on osteoarthritis and musculoskeletal disorders, as well as oncology and dermatology diseases. The Company's portfolio of therapeutic products is being developed using stem cell and immune oncology technology platforms. The Company's technology platform includes approximately three platforms across both human and animal health businesses, including Human and animal adipose-derived mesenchymal stem cells (MSCs) for the treatment of musculoskeletal diseases; Human and animal immunotherapy personalized cancer vaccine for the treatment of various cancers, and Stem cell secretions cell free supernatant (CFS) technology harnessing the therapeutic potential of mesenchymal stem cells for skincare treatments. The Company's products include Kvax, CryoShot, Progenza, Human Cancer Vaccine and Secretions Cream.
Biotechnology Cancer Biology Life Sciences Stem Cells Cancers Regenerative Medicine Cell Biology Induced Stem Cells Mesenchymal Stem Cell Therapeutic Products Immunotherapy Stem Cell Therapy

Is RGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.22
52 Week Low 0.06
Average Volume 99,608
200-Day Moving Average 0.114
50-Day Moving Average 0.079
20-Day Moving Average 0.085
10-Day Moving Average 0.094
Average True Range 0.006
ADX 21.3
+DI 41.472
-DI 37.150
Chandelier Exit (Long, 3 ATRs ) 0.096
Chandelier Exit (Short, 3 ATRs ) 0.083
Upper Bollinger Band 0.106
Lower Bollinger Band 0.064
Percent B (%b) 0.45
BandWidth 48.528
MACD Line 0.004
MACD Signal Line 0.004
MACD Histogram 0.0001
Fundamentals Value
Market Cap 17.34 Million
Num Shares 209 Million
EPS 0.02
Price-to-Earnings (P/E) Ratio 5.19
Price-to-Sales 2.70
Price-to-Book 3.33
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.101
Resistance 3 (R3) 0.103 0.099 0.098
Resistance 2 (R2) 0.099 0.094 0.098 0.097
Resistance 1 (R1) 0.091 0.092 0.089 0.089 0.096
Pivot Point 0.087 0.087 0.086 0.086 0.087
Support 1 (S1) 0.079 0.082 0.077 0.077 0.070
Support 2 (S2) 0.075 0.080 0.074 0.069
Support 3 (S3) 0.067 0.075 0.068
Support 4 (S4) 0.065